Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS
· Delayed Price · Currency is USD
0.4899
+0.0499 (11.33%)
Apr 24, 2025, 12:49 PM EDT
Pharma-Bio Serv Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2015 - 2019 |
| Revenue | 9.6 | 9.51 | 16.98 | 19.4 | 20.12 | 21.56 | Upgrade
|
| Revenue Growth (YoY) | -36.50% | -43.99% | -12.48% | -3.56% | -6.72% | 10.55% | Upgrade
|
| Cost of Revenue | 6.85 | 6.99 | 11.91 | 14.52 | 14.76 | 14.9 | Upgrade
|
| Gross Profit | 2.75 | 2.52 | 5.07 | 4.88 | 5.36 | 6.67 | Upgrade
|
| Selling, General & Admin | 3.69 | 3.8 | 3.95 | 3.71 | 4.01 | 4.44 | Upgrade
|
| Operating Expenses | 3.69 | 3.8 | 3.95 | 3.71 | 9.21 | 4.44 | Upgrade
|
| Operating Income | -0.94 | -1.29 | 1.12 | 1.17 | -3.85 | 2.23 | Upgrade
|
| Interest Expense | -0.03 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.53 | 0.53 | 0.57 | 0.01 | 0.02 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | -0.49 | -0.76 | 1.69 | 1.19 | -3.83 | 2.29 | Upgrade
|
| Other Unusual Items | - | - | - | - | 1.96 | - | Upgrade
|
| Pretax Income | -0.49 | -0.76 | 1.69 | 1.19 | -1.88 | 2.29 | Upgrade
|
| Income Tax Expense | 0.01 | 0.02 | 0.38 | 0.18 | 0.21 | 0.24 | Upgrade
|
| Earnings From Continuing Operations | -0.5 | -0.78 | 1.31 | 1.01 | -2.09 | 2.05 | Upgrade
|
| Net Income | -0.5 | -0.78 | 1.31 | 1.01 | -2.09 | 2.05 | Upgrade
|
| Net Income to Common | -0.5 | -0.78 | 1.31 | 1.01 | -2.09 | 2.05 | Upgrade
|
| Net Income Growth | - | - | 30.15% | - | - | -1.74% | Upgrade
|
| Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | -0.17% | -0.10% | -0.15% | -0.56% | 0.53% | -0.32% | Upgrade
|
| EPS (Basic) | -0.02 | -0.03 | 0.06 | 0.04 | -0.09 | 0.09 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.03 | 0.06 | 0.04 | -0.09 | 0.09 | Upgrade
|
| EPS Growth | - | - | 30.25% | - | - | -1.11% | Upgrade
|
| Free Cash Flow | -1.88 | -0.73 | 1.88 | 0.57 | 0.79 | 1.46 | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.03 | 0.08 | 0.03 | 0.03 | 0.06 | Upgrade
|
| Gross Margin | 28.63% | 26.46% | 29.84% | 25.16% | 26.65% | 30.91% | Upgrade
|
| Operating Margin | -9.81% | -13.54% | 6.58% | 6.06% | -19.16% | 10.32% | Upgrade
|
| Profit Margin | -5.19% | -8.18% | 7.72% | 5.19% | -10.39% | 9.51% | Upgrade
|
| Free Cash Flow Margin | -19.59% | -7.64% | 11.10% | 2.96% | 3.95% | 6.77% | Upgrade
|
| EBITDA | -0.92 | -1.26 | 1.17 | 1.23 | -3.78 | 2.31 | Upgrade
|
| EBITDA Margin | -9.54% | -13.30% | 6.87% | 6.32% | -18.80% | 10.72% | Upgrade
|
| D&A For EBITDA | 0.03 | 0.02 | 0.05 | 0.05 | 0.07 | 0.09 | Upgrade
|
| EBIT | -0.94 | -1.29 | 1.12 | 1.17 | -3.85 | 2.23 | Upgrade
|
| EBIT Margin | -9.81% | -13.54% | 6.58% | 6.06% | -19.16% | 10.32% | Upgrade
|
| Effective Tax Rate | - | - | 22.36% | 15.29% | - | 10.44% | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.